D-dimer and CoV-2 spike-immune complexes contribute to the production of PGE2 and proinflammatory cytokines in monocytes

• Yun-Jong Park,

  Roles Formal analysis, Investigation, Methodology, Writing – original draft

  Affiliation Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland, United States of America

  https://orcid.org/0000-0002-6263-5437

  ⨯
• David Acosta,

  Roles Investigation

  Affiliation Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland, United States of America

  https://orcid.org/0000-0001-7515-2111

  ⨯
• Russell Vassell,

  Roles Investigation

  Affiliation Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland, United States of America

  ⨯
• Juanjie Tang,

  Roles Investigation

  Affiliation Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland, United States of America

  https://orcid.org/0000-0002-5791-6082

  ⨯
• Surender Khurana,

  Roles Resources

  Affiliation Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland, United States of America

  ⨯
• Carol D. Weiss,

  Roles Resources

  Affiliation Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland, United States of America

  ⨯
• Hana Golding,

  Roles Funding acquisition, Writing – review & editing

  Affiliation Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland, United States of America

  ⨯
• Marina Zaitseva

  Roles Conceptualization, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: marina.zaitseva@fda.hhs.gov

  Affiliation Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland, United States of America

  https://orcid.org/0000-0002-4785-5861

  ⨯